Literature DB >> 16473525

High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics.

Markus S Birringer1, Remo Perozzo, Elvan Kut, Corinne Stillhart, Wanda Surber, Leonardo Scapozza, Gerd Folkers.   

Abstract

Human cytosolic thymidine kinase (hTK1) is the key enzyme of the pyrimidine salvage pathway and phosphorylates thymidine to thymidine monophosphate, a precursor building block of the DNA. Wild-type hTK1 (hTK1W) as well as a truncated form of the enzyme (hTK1M) carrying deletions at the N- and C-terminal regions were cloned as His(6)-tagged fusion proteins. Expression, isolation, and purification protocols have been established, leading to high yields of soluble and active wild type (approximately 35 mg) and truncated hTK1 (approximately 23 mg) per liter of culture. The protein was purified to near homogeneity. The chaperone DnaK was identified to be the major contaminant that could be removed by applying an additional ATP-MgCl(2) incubation and washing step. hTK1W was a permanent tetramer in solution, whereas the truncated construct hTK1M appears to be a dimer in absence and presence of substrates. Both hTK1W and hTK1M exhibit pronounced thermal stability with transition temperatures (T(m)) of 71.7 and 73.4 degrees C, respectively, when measured without adding substrates. The presence of substrates stabilized both hTK1W (DeltaT(m) ranging from 5.6 to 12.5 degrees C) and hTK1M (DeltaT(m) ranging from 0.8 to 5.3 degrees C). Both enzymes show high activity over a broad range of pH, temperature, and ionic strength. Kinetic studies determined a K(M) of 0.51 microM and a k(cat) of 0.28 s(-1) for wild-type hTK1. The truncated hTK1M has a K(M) of 0.87 microM and k(cat) of 1.65 s(-1), thus exhibiting increased catalytic efficiency. The availability of recombinant human TK1 will facilitate further biochemical and crystallographic studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473525     DOI: 10.1016/j.pep.2006.01.001

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  13 in total

1.  Production of recombinant proteins in the lon-deficient BL21(DE3) strain of Escherichia coli in the absence of the DnaK chaperone.

Authors:  Julien Ratelade; Marie-Caroline Miot; Emmett Johnson; Jean-Michel Betton; Philippe Mazodier; Nadia Benaroudj
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

2.  Prodrug activation by Cryptosporidium thymidine kinase.

Authors:  Xin E Sun; Lisa Sharling; Mani Muthalagi; Devaraja G Mudeppa; Krzysztof W Pankiewicz; Krzysztof Felczak; Pradipsinh K Rathod; Jan Mead; Boris Striepen; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

3.  Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure.

Authors:  Dario Segura-Peña; Stefan Lutz; Christian Monnerjahn; Manfred Konrad; Arnon Lavie
Journal:  J Mol Biol       Date:  2007-03-15       Impact factor: 5.469

4.  Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET imaging agent for HSV1-tk gene expression.

Authors:  Ursina Müller; Tobias L Ross; Charlene Ranadheera; Roger Slavik; Adrienne Müller; Mariana Born; Evelyn Trauffer; Selena Milicevic Sephton; Leonardo Scapozza; Stefanie D Krämer; Simon M Ametamey
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

5.  PET Radiotracers for Imaging the Proliferative Status of Solid Tumors.

Authors:  Robert H Mach; Farrokh Dehdashti; Kenneth T Wheeler
Journal:  PET Clin       Date:  2009-01-01

6.  Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.

Authors:  Saugata Hazra; Elisabetta Sabini; Stephan Ort; Manfred Konrad; Arnon Lavie
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

7.  Crystal structures of T. b. rhodesiense adenosine kinase complexed with inhibitor and activator: implications for catalysis and hyperactivation.

Authors:  Sabine Kuettel; Jason Greenwald; Dirk Kostrewa; Shaheen Ahmed; Leonardo Scapozza; Remo Perozzo
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

8.  Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.

Authors:  Jennifer Timm; Cristina Bosch-Navarrete; Eliseo Recio; Joanne E Nettleship; Heather Rada; Dolores González-Pacanowska; Keith S Wilson
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

9.  Mass action models versus the Hill model: an analysis of tetrameric human thymidine kinase 1 positive cooperativity.

Authors:  Tomas Radivoyevitch
Journal:  Biol Direct       Date:  2009-12-09       Impact factor: 4.540

10.  Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.

Authors:  Sharif Hanan; Kiran Kumar Jagarlamudi; Wang Liya; He Ellen; Eriksson Staffan
Journal:  BMC Biochem       Date:  2012-06-28       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.